Articles related to CLINICAL STUDY

A meta-analysis of 99 randomized controlled trials suggests that vitamin D supplementation may offer significant cardiometabolic benefits, with the greatest improvements seen in specific population subgroups.

A randomized controlled trial involving 108 adults with metabolic syndrome found that implementing an 8- to 10-hour time-restricted eating window, in addition to standard-of-care treatments, resulted in a 0.10% reduction in HbA1c levels compared to standard care alone.

A prospective study involving over 170,000 participants from the UK Biobank found that moderate coffee consumption (3 drinks/day) was associated with a 48.1% lower risk of developing cardiometabolic multimorbidity compared to non-consumers.

Recent research comparing SGLT2 inhibitors and dulaglutide in older patients with type 2 diabetes suggests a potential difference in dementia risk. The study estimated a risk ratio of 0.81 (CI, 0.56 to 1.16) for SGLT2 inhibitors compared to dulaglutide.

Recent data shows a significant increase in pulmonary vein isolation procedures for atrial fibrillation among older adults, with concurrent decreases in complication and hospitalization rates.

The study found that psychosocial factors had the most significant impact on postmenopausal women’s quality of life, with 26.6% of participants reporting accomplishing less than usual.